Drug Approval | June 12, 2024
Glenmark receives ANDA approval for Esomeprazole Magnesium Delayed-Release capsules
Glenmark's current portfolio consists of 197 products authorized for distribution in the U.S. marketplace
Glenmark's current portfolio consists of 197 products authorized for distribution in the U.S. marketplace
Accelerating sustainability in Indian pharma industry
his strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL's journey towards expanding its healthcare portfolio
HaystackAnalytics is engaged in the business of developing genomic analysis software
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
Sleep disturbances are among the most frequent and disruptive symptoms associated with menopause which can impact women’s health and quality of life
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
This acquisition complements AstraZeneca’s leading oncology portfolio with the addition of the Fusion pipeline of RCs
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
Subscribe To Our Newsletter & Stay Updated
